New dual inhibitors of EGFR and HER2 protein tyrosine kinases |
| |
Authors: | Fink Brian E Vite Gregory D Mastalerz Harold Kadow John F Kim Soong-Hoon Leavitt Kenneth J Du Karen Crews Donald Mitt Toomas Wong Tai W Hunt John T Vyas Dolatrai M Tokarski John S |
| |
Affiliation: | Department of Oncology Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543-4000, USA. brian.fink@bms.com |
| |
Abstract: | ![](https://cache.aipub.cn/images/ars.els-cdn.com/content/image/1-s2.0-s0960894x05009571-fx1.jpg) A novel series of dual EGFR and HER2 inhibitors based on the pyrrolo[2,1-f][1,2,4]triazine nucleus is described. A general route toward their synthesis, which enables functionalization at multiple sites, has been developed. Biological evaluation in enzymatic and cell-based assays has identified a series of C-6 carbamates with potent biochemical and cellular activities. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|